Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.
Also called NCT07397845
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,380 participants
- Sponsor
- Translumina GmbH
- Registry
-
NCT07397845
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Recruiting
Technical summary
Registry record NCT07397845. Randomized; no masking; primary purpose treatment. Start 2026-04-22 (actual); primary completion 2028-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
- Acronym
- SPARX RCT
- Condition
- Coronary Artery Disease
- Condition
- Drug Eluting Balloon
- Condition
- Drug Eluting Stent
- Intervention (Device)
- Protégé and Protégé NC
- Intervention (Device)
- Agent
- Intervention (Device)
- Drug Eluting Stent
- Lead sponsor
- Translumina GmbH
Record details
- Record id
cardio:ct-nct07397845- Content hash
f8fe537e4327dd44ee0e0d510edf16e6308f23604874e07e0e3f1040aebdd502